- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA case AUTH/3074/9/18 (Director v AbbVie) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
Efient leavepiece used prominent 15‑month subgroup/landmark data and downplayed overall bleeding risk. PMCPA ruled it misleading, inconsistent with SPC (12‑month recommendation), and…
A GP complained about faxed advisory board invitations addressed to “All GPs” and an unnamed recipient, plus inconsistent fees. PMCPA found a…
Novo Nordisk co-sponsored an evening restaurant meeting in Dec 2011 that invitees saw as a Christmas meal. PMCPA found breaches of Clauses…
Anonymous clinician alleged a Lilly/Boehringer Ingelheim diabetes meeting was a sales event disguised as education. Panel found the meeting had clear educational…
A health professional complained that a symposium invite referencing “new data from clinical trials” implied promotion of unpublished/unlicensed information. The Panel found…
Baxter UK was ruled in breach of Clause 9.1 after exhibiting at a Northern Ireland urology meeting held at a 5-star venue…
Anonymous complaint alleged a retrospective rebate for Cerazette to counter generics, said to be an inducement to prescribe (Clauses 2, 18.1). MSD…
A rep emailed a GP practice about Zostavax supply, highlighting “£26 per dose profit” and providing a patient-invite template. No breach of…
Anonymous complaint about Rienso ad and anaemiazone.co.uk. Panel upheld ‘high dose’ claim, but ruled breaches for calling Rienso ‘new’, outdated competitor dosing…
Allergan press release (reproduced in two UK publications) discussed Moers‑Carpi data in isolation, implying Bocouture/Xeomin was less potent than Vistabel/Botox. PMCPA found…
A hospital doctor said GSK’s ‘do more, feel better, live longer’ strapline on a BTS stand invitation implied respiratory medicines (incl. Seretide)…
Anonymous neurologist alleged excessive rep pressure and use of uncertified materials. Panel found no breach on call rates/meeting pressure due to lack…
Genzyme materials for an NHS-linked advisory group meeting compared Fabrazyme vs Replagal, used “biosimilar” language and cost-switch messaging, omitted key SPC caveats…
AbbVie alleged a BMS-sponsored BSR 2015 symposium was disguised promotion encouraging off-licence abatacept use. The PMCPA Panel found the event was legitimate…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.